I-Corps: A wearable device for continuous, real-time, and multiplexed monitoring of biomarkers present in interstitial fluid
I-Corps: A wearable device for continuous, real-time, and multiplexed monitoring of biomarkers present in interstitial fluid
批准号:
2218926
负责人:
Susan Tapert
金额:
$5.0万
依托单位国家:
美国
项目类别:
Standard Grant
财政年份:
2022
资助国家:
美国
项目状态:
已结题
起止时间:
2022-04-01 至 2022-09-30
中文摘要
点击翻译按钮获取中文摘要
英文摘要
The broader impact/commercial potential of this I-Corps project is the development of a pain-free, lab-under-the-skin wearable technology for continuous, and real-time monitoring of multiple biomarkers of significance such as alcohol, glucose, lactate, ketone bodies, testosterone, cortisol, insulin, and more. The proposed lab-under-the-skin device may potentially promote public health for the treatment and prevention of alcohol misuse, more effective management of diabetes in the ever-growing population of people affected with diabetes, and timely diagnosis, treatment, and recovery of infectious diseases such as sepsis in hospitals or at-home settings. In addition, the device may be adopted for performance, health, and fitness use cases, which may aid in educating individuals in understanding their own physiology and metabolism, and personalized nutrition.This I-Corps project is based on the development of a wearable sensor for continuous monitoring of model analytes namely alcohol, glucose, and lactate. The proposed technology is based on a quarter-sized electrochemical sensor that uses a microneedle array with wireless communication to the wearer’s smartphone. The barely visible micron-scale array of microneedles enables continuous access to the molecular information-rich biofluid beneath the skin in a pain- and discomfort-free manner. The preliminary results of continuous monitoring were promising for all investigated biomarkers, with the sensors’ data being in perfect correlation with those obtained from gold-standard metrics. Product and market validation activities by the interviews with potential end-users, decision-makers, and influencers throughout this I-Corps project will bring increased certainty and focus during the product development efforts on the choice of biomarkers that are immediate needs of the prospect market segments. In addition, the goal is to address the true need of the end-user, and to develop what has tangible commercial value and a broader impact on society.This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
RAPID: Impact of the COVID-19 Pandemic on Child Development in the ABCD Cohort
-
批准号:2028680
-
项目类别:Standard Grant
-
资助金额:$20.0万
-
财政年份:2020
-
负责人:Susan Tapert
-
依托单位:
海外基金